NICE approves first NHS treatment for advanced blood cancer

The National Institute for Health and Care Excellence (NICE) has recommended brentuximab vedotin (Adcetris; Takeda), in combination with other chemotherapy drugs, as the first NHS treatment for untreated late-stage classical Hodgkin lymphoma. In final draft guidance, published on 2 April 2025, NICE said that up to 800 people per year with previously untreated stage 3 […]

Publication Details

Journal: Pharmaceutical journal/The pharmaceutical journal
Published: 2025-01-01
DOI: https://doi.org/10.1211/pj.2025.1.352425
Primary Topic: Healthcare Systems and Challenges
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

NICE approves first NHS treatment for advanced blood cancer

Jan 1, 2025

Pharmaceutical journal/The pharmaceutical journal

Healthcare Systems and Challenges

article

NICE approves first NHS treatment for advanced blood cancer

January 1, 2025article en

Abstract

Pharmaceutical journal/The pharmaceutical journal

Good health and well-being

Openalex Percentile: Top 89%

Healthcare Systems and Challenges

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

NICE approves first NHS treatment for advanced blood cancer · Pharmaceutical journal/The pharmaceutical journal (2025) | TGRS Research Map | TGRS